Approval · Notice of Compliance 8064 · 2006
SINGULAIR: Notice of Compliance 8064
Issued June 20, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8064
- Date
- June 20, 2006
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updates to the indications and clinical use, warnings and precautions and adverse reactions sections of the product monograph
- Therapeutic class
- Leukotriene receptor antagonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SINGULAIR | Not yet assigned | — |
Medicinal ingredients
- MONTELUKAST SODIUM 10 MG per TAB
- MONTELUKAST SODIUM 5 MG per TAB
- MONTELUKAST SODIUM 4 MG per TAB
- MONTELUKAST SODIUM 4 MG per PCK